Reid Hoffman leaves Microsoft board to focus on AI drug startup Manus
After a decade on Microsoft’s board, venture partner Reid Hoffman steps down to work full‑time on Manus, his AI‑driven drug discovery venture. Manus, co‑founded with Pulitzer‑winning oncologist Siddhartha Mukherjee, raised over $50 million and aims to accelerate cancer‑fighting chemistry.